Come up with a name for your new list and we'll add to it:
Alcyone Lifesciences raised a round of funding on March 27, 2012. Investors include
Harbor Light Capital Partners.
Alcyone Lifesciences is focused on developing products for the treatment of difficult neuropathological conditions. For many neurologic conditions there are identified molecular targets, but the blood…